Who invested in Apitope?
Apitope's investors include LRM, Vesalius Biocapital III, Wales Life Sciences Investment Fund, PMV Pharmaceutcals and Wyvern Seed Fund.

United Kingdom · Series B startup
Funding summaryUpdated 26 Oct 2026
$13Mraised across 1 round since 2015, from 1 source
From a historical funding record
Apitope's investors include LRM, Vesalius Biocapital III, Wales Life Sciences Investment Fund, PMV Pharmaceutcals and Wyvern Seed Fund.
Apitope has raised $13M across 1 round since 2015.
Apitope's most recent round was a Series B of $13M in Sept 2015.
Its most recent round, $13M in Sept 2015, is also its largest on record.
Apitope's first round on record, in Sept 2015, was backed by LRM, Vesalius Biocapital III and Wales Life Sciences Investment Fund and 2 others.
Apitope's latest named round is a Series B, in Sept 2015.
Apitope is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.